The Basic Act on Hepatitis Countermeasures issued in 2009 states the comprehensive measures that can be taken against viral hepatitis as well as the responsibility that the national government, local governments, health insurance provides, physicians, and citizens should take in these measures, thereby organically facilitating the construction of a hepatitis management system in Japan. In addition, the Committee for the Clinical Management of Hepatitis has established branches in each prefecture to create a hepatitis management network for public hepatitis screening facilities, primary care physicians, medical institutions specializing in hepatitis, and primary hospitals for cooperative medical care of liver diseases to address regional hepatitis-related issues.
| INTRODUCTION
In Japan, more than 70% of cirrhosis cases are caused by viral infection with either hepatitis C virus or hepatic B virus (60.9% caused by HCV and 12.0% by HBV, respectively), 1 and persistent HCV infection is responsible for approximately 70% of deaths from hepatocellular carcinoma. When untreated, viral hepatitis is likely to progress to cirrhosis and subsequently to liver cancer without giving rise to subjective symptoms; therefore, it is necessary to establish highly effective countermeasures. Japanese citizens undergo screening for hepatitis (by any cause) at least once in a lifetime and then subsequent comprehensive examination and antiviral therapy (or liver support therapy in those contraindicated for antiviral therapy) as first-line treatment for as long as possible when the screening result is positive. The current mainstream drug for HCV is direct-acting antivirals (DAAs). DAAs therapy is curative in more than 90% of chronic hepatitis C patients). [2] [3] [4] The seamless operation of this three-step (screening, diagnosis, and treatment) system is essential for the management of hepatitis and liver cancer. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
hepatitis viral infection and of patients with hepatitis while also providing high-quality, appropriate medical care. This has led to the nationwide practice of measures against hepatitis and liver cancer, in order to realize the early detection and early treatment of hepatitis.
Article 1 of the Basic Act on Hepatitis Countermeasures declares
that the Act aims to promote the measures against hepatitis comprehensively by clarifying the responsibility that the national government, local governments, health insurance provides, physicians, and citizens should take; by establishing guidelines for the promotion of the measures; and by specifying the fundamentals of the measures (Table 1) . We review the latest polices of hepatitis in this article.
| Prevention, care
, and treatment of hepatitis, cirrhosis, and liver cancer caused by hepatitis viruses (written as "hepatitis management" in the guidelines)
In Paragraph 2 of Article 9, Item 1 generalizes the contents of items 2-9.
It is important to follow this idea to proceed seamlessly with the abovementioned three steps: screening, diagnosis, and treatment (Table 1) .
First, Japanese citizens should be screened for hepatitis at least once. The risk factors for infection by HBV and HCV are family history, a history of blood transfusion or surgery, and the use of blood products. However, it is unwise to limit consideration to only these risk factors, due to the involvement of other factors in previous cases of HBV and HCV infection. Therefore, it is important for all prefectures to establish a screening system for hepatitis and urge residents to undergo screening. As of December 2015, hepatitis screening is provided free of charge in every prefecture, city with a public health center, and Tokyo special ward (Table 2 ). Therefore, it will be necessary to develop a channel dedicated to provide health-related information including hepatitis.
A follow-up study of 272 Saga residents who were diagnosed as being HCV-positive in the free hepatitis screening provided by the prefecture since 2008 showed that 194 subsequently underwent comprehensive examination and only 32 of those were treated in antiviral therapy. 6 This means that 78 and 41 HCV-positive residents dropped out of the system before undergoing comprehensive examination and the indicated interferon treatment, respectively. Therefore, factors that cause these dropouts at each step must be investigated to establish appropriate measures against dropouts.
| Establishing a system to screen for hepatitis
With the causal factors of live cancer in mind, the first step toward efficiently tracking down high-risk groups is to screen for residents
The basic act on hepatitis countermeasures and the basic guidelines for the prevention and management of hepatitis (excerpt)
Article 1:
This Act hereby declares the basic principles of the measures against hepatitis; clarifies, in relation to the measures, the responsibility of the national government, local governments, health insurance provides, citizens, and physicians; and promotes the measures against hepatitis comprehensively by determining the fundamental issues in the measures and establishing guidelines to promote the measures
Article 9:
The 
4.
To educate patients about periodically visiting specialized medical institutions for the early detection of liver cancer even when patients have been treated by their primary care physicians.
In addition, prefectural and municipal governments will actively gather information on medical care for liver diseases provided at individual medical institutions, and the information on the treatments and the names of institutions will be released using media such as the Internet, public relations magazines, and posters. In addition, the governments create leaflets about the local clinical treatment system for liver diseases and develop hepatitis patient notebooks, as it is essential to make the hepatitis management network common knowledge among local residents.
The roles and requirements that primary care physicians, specialized medical institutions, and primary hospitals for the cooperative medical care of liver diseases should play and fulfill are as follows: It is necessary to not only maintain this framework, but also construct an organic and human network to realize an ideal system of cooperative medical care between primary care physicians, who introduce medical institutions specialized in liver diseases at least once, and specialized medical institutions, which introduce primary care physicians after comprehensive examination. 
| CONCLUSION
In Japan, the hepatitis management system is being constructed organically owing to the specification of the roles of the national government, local governments, citizens, and primary care physicians and other healthcare professionals, including specialists, in the Basic Act on Hepatitis Countermeasures. The establishment of a proper clinical treatment system, especially a cooperative medical care system, is underway for various diseases other than liver diseases, but the hepatitis management system is innovative because it was designed and is currently operated to manage the disease nationwide. However, many Japanese citizens have not yet undergone hepatitis screening, or even are unaware of the disease. In addition, some individuals do not take any action even though they are aware that they carry the hepatitis virus. Consequently, in daily clinical practice, we encounter many cases of hepatitis with no ideal treatment approach due to the lack of early treatment. As the aging of patients with viral hepatitis progresses, it is important for all the players in the treatment of hepatitis to cooperate more closely to address challenges.
